华恒生物：2025年净利润同比减少30.97%

Core Insights - The company reported a revenue of 2.886 billion yuan for the fiscal year 2025, representing a year-on-year growth of 32.50% [1] - The net profit attributable to shareholders decreased to 131 million yuan, reflecting a year-on-year decline of 30.97% [1] - The basic earnings per share (EPS) was 0.52 yuan, down 36.59% compared to the previous year [1]